When analyzing CD11b and CD11c markers to further distinguish CD45+ cells, no distinct cell populations were identified, indicating that tumor-infiltrating myeloid cells express varying levels of CD11b and CD11c. The gene discussed is ITGAM; the disease is neoplasm.